Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityNo recent work listed

Xiandong Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8106-2833; OpenAlex author ID A5085689918. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. Agrimoniin sensitizes pancreatic cancer to apoptosis through ROS-mediated energy metabolism dysfunction. Co-author DOI 10.1016/j.phymed.2021.153807↗
  2. High Glucose-Induced ROS Production Stimulates Proliferation of Pancreatic Cancer via Inactivating the JNK Pathway. Co-author DOI 10.1155/2018/6917206↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bicheng Chen · 2 shared papers, 2018–2022 · strength 0.23
  2. Linxiao Sun · 1 shared paper, 2022 · strength 0.15
  3. Hewei Zhang · 1 shared paper, 2022 · strength 0.15
  4. Jiao Min Luo · 1 shared paper, 2018 · strength 0.08
  5. Fubiao Ni · 1 shared paper, 2018 · strength 0.08
  6. Li Ding · 1 shared paper, 2018 · strength 0.08
  7. Yukai Xiang · 1 shared paper, 2018 · strength 0.08
  8. Mengtao Zhou · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.